Close
 Indian J Med Microbiol  
 

Figure 2 (A-C): Growing FNH in a 30-year-old female. Arterial-phase image of a gadobenate dimeglumine-enhanced MRI (A) shows a homogeneously enhancing mass (arrow) with a central nonenhancing scar. It measures 2.5 cm in its maximum dimension. Eighteen-month follow-up dimeglumine-enhanced MRI in the arterial phase (B) shows an interval increase in the size of the mass (arrow) to 3.1 cm. The mass (arrow) is slightly hyperintense relative to the liver in the hepatobiliary-specific phase (2-h delay) (C), with a central nonenhancing scar; the appearance is consistent with FNH

Figure 2 (A-C): Growing FNH in a 30-year-old female. Arterial-phase image of a gadobenate dimeglumine-enhanced MRI (A) shows a homogeneously enhancing mass (arrow) with a central nonenhancing scar. It measures 2.5 cm in its maximum dimension. Eighteen-month follow-up dimeglumine-enhanced MRI in the arterial phase (B) shows an interval increase in the size of the mass (arrow) to 3.1 cm. The mass (arrow) is slightly hyperintense relative to the liver in the hepatobiliary-specific phase (2-h delay) (C), with a central nonenhancing scar; the appearance is consistent with FNH